Educational only. Not medical advice. Invite-only research preview.No PHI. Do not share patient names or identifying information (HIPAA).
MytoIntelligence
All targets

Molecular target

Xanthine Oxidase

Enzyme catalyzing the final two steps of purine catabolism (hypoxanthine → xanthine → uric acid). Inhibition (allopurinol, febuxostat) lowers serum urate — basis for gout and tumor lysis prophylaxis. Allopurinol is also a substrate-pathway inhibitor for thiopurines (azathioprine, 6-MP).

2 drugs act here22 plants reach it via their compounds

Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.

No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.

Pharmaceutical agents

Drugs that act on Xanthine Oxidase

These medications have Xanthine Oxidase among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.

Botanical connections

Plants whose compounds act on Xanthine Oxidase

Each plant below contains a named compound documented to act on Xanthine Oxidase. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.

  • Gallic acidPhenolic acid

    Preclinical studies report gallic acid attenuates LPS-induced NF-κB activation and modulates the Akt/AMPK/Nrf2 pathway; earlier work identified it as the principal hepatoprotective constituent in T. bellirica fruit fractions.

  • Tannins (ellagitannins, gallotannins)Polyphenol

    In vitro antioxidant and ROS-scavenging studies associate the tannin-rich fruit extract with free-radical quenching and reported xanthine oxidase inhibition; activity correlates with total phenolic content.

  • Gallic acidPolyphenol / Ellagitannin metabolite

    In vitro studies report ROS scavenging and NF-κB modulation; contributes to reported antioxidant and anti-inflammatory activity.

  • Ellagic acidPolyphenol

    Preclinical data report antioxidant and anti-inflammatory signalling; oral bioavailability is limited.

  • Rutin (quercetin-3-rutinoside)Flavonoid glycoside

    Rutin is the predominant flavonoid in buckwheat. Cell culture studies reviewed by Borgonovi et al. (2024) report antioxidant, anti-inflammatory, and vascular-related signalling activity. Xanthine oxidase inhibition and modulation of NO/cGMP pathways have been investigated in preclinical models. Clinical translation remains under-characterised.

  • Rutin (quercetin-3-rutinoside)Flavonoid glycoside

    Preclinical studies report NF-κB pathway and COX-2 modulation; xanthine oxidase inhibitory activity investigated in vitro (Zhang et al. 2018; Annaz et al. 2022)

  • Gentisin / xanthones and phenolic constituents

    G. lutea xanthone/phenolic constituents have documented xanthine oxidase inhibitory activity in vitro; offered as a compound-specific enzyme-inhibition link. Preclinical only.

  • QuercetinFlavonoid

    Isolated from OFI stems and fruit; preclinical studies report inhibition of xanthine oxidase-mediated oxidative neuronal injury and modulation of COX-2 and NF-κB pathways at tested concentrations. Clinical translation unestablished.

  • Caffeic acidPhenolic acid

    In vitro antioxidant and xanthine oxidase inhibitory activity reported; contribution to in vivo effects is uncertain.

  • Sesamol / Sesamin

    Sesame lignans (notably sesamol) have documented direct xanthine oxidase inhibitory activity in enzymatic assays, contributing to antioxidant effects via reduced superoxide and uric acid generation.

  • Flavonoids (rutin, quercetin, kaempferol)Flavonoids

    Preclinical data report anti-inflammatory activity via NF-κB and COX-2 pathway modulation, and antioxidant activity including xanthine oxidase inhibition.

  • Anthocyanins / phenolic acidsPolyphenol

    In vitro antioxidant activity reported; may involve nitric oxide pathway modulation and free-radical scavenging.

  • Polyphenol / tannin fractionPolyphenols

    In vitro antioxidant activity has been partly attributed to xanthine oxidase inhibition and free-radical scavenging.

  • Polyphenols / flavonoid glycosidesPolyphenols

    Olas et al. (2024) reviews in vitro evidence for anti-inflammatory activity attributed in part to flavonoid and polyphenol constituents, including reported modulation of COX-2, TNF-α, and xanthine oxidase pathways; clinical relevance in humans requires further investigation.

  • Piper betle leaf extract (unfractionated)Polyherbal extract

    Animal (broiler) study reported reduced uric acid levels compared with gout-induced controls, with xanthine oxidase inhibition proposed as a contributing mechanism alongside antioxidant activity; direct human data are lacking.

  • quercetin

    Quercetin is a well-documented, potent inhibitor of xanthine oxidase, a compound-specific flavonoid mechanism relevant to the antioxidant/anti-inflammatory profile of Calluna vulgaris extracts.

  • Emblicanin A / Emblicanin BHydrolysable tannins

    Reviewed as contributing to antioxidant and anti-inflammatory activity in vitro; xanthine oxidase inhibition reported in mechanistic literature.

  • Quercetin / HyperosideFlavonoid

    Quercetin has been studied as a xanthine oxidase inhibitor and NF-κB modulator in preclinical settings; direct extrapolation to Chimaphila umbellata extracts is speculative.

  • Ellagitannins / Ellagic acidHydrolysable tannins / Phenolic acids

    Preclinical data suggest inhibition of NF-κB pathway and xanthine oxidase; urolithins generated by gut microbial metabolism of ellagitannins are considered the primary bioactive metabolites in vivo.

  • Luteolin / Apigenin / Taxifolin (flavonoids)

    Luteolin and apigenin are well-documented, structurally specific xanthine oxidase inhibitors; this flavonoid–XO interaction is widely studied and relevant to tamarind's flavonoid-rich leaf/pulp extracts.

  • Gallic acid / ellagic acid (and chebulagic/chebulinic acid)

    Triphala polyphenols, notably gallic acid and ellagic acid, are documented xanthine oxidase inhibitors. This is a specific, well-studied enzyme-inhibition link (relevant to the antioxidant/anti-hyperuricemic effects), not a generic anti-inflammatory claim.

  • gallic acid

    Gallic acid and ellagic acid are documented, well-characterized inhibitors of xanthine oxidase, with compound-specific enzyme-kinetic data (competitive/mixed inhibition). Both are named constituents of Rhus glabra, so the link is specific rather than a generic antioxidant attribution.

  • Ellagitannins / Ellagic acidHydrolysable tannin / polyphenol

    Identified as predominant constituents of bur extracts (Esposito et al. 2019); in vitro antioxidant and radical-scavenging activity reported. Xanthine oxidase inhibition is mechanistically proposed in polyphenol literature but not yet confirmed for C. sativa extracts specifically.

  • Mangiferin

    Mangiferin, a xanthone present in Swertia chirata, has documented compound-specific activation of AMPK (well-characterized in metabolic/antidiabetic studies). This is a named-compound, target-specific link rather than generic attribution.

A shared molecular target shows how a botanical and a drug relate mechanistically. It is not evidence that one can replace the other. Educational summary only — discuss any medication decision with your clinician.